Project Grant HT94252411052
Award Date
9/15/24
Completion Date
9/14/28
Dollars Obligated
$7.7M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01655, USA
Similar Awards
This federal Project Grant award for $3,854,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is funding research at the University of Massachusetts Medical School (UMass Medical) to target human respiratory viruses and host sequences with respiratory-active RNAs. The award, which runs from September 1, 2025 to August 31, 2029, supports advanced biomedical research aimed at transforming healthcare for military service...
The U.S. Defense Health Agency awarded a $7,349,780 Project Grant to the University of Massachusetts Medical School (UMass Medical) to conduct research on "RNA Therapeutics for Infectious Diseases: Viral Hemorrhagic Fever" over a 4-year period from September 1, 2023 to August 31, 2027. This grant is funded through the Department of Defense's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to develop innovative medical solutions for...
This Project Grant award, totaling $757,212.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Massachusetts Medical School Grants and Contracts Administration Division for the "PRECLINICAL DEVELOPMENT OF AN ORAL NANOBODY PROPHYLACTIC TO PREVENT DIARRHEAL DISEASE." The funding will support research and development of an oral nanobody-based therapeutic to prevent diarrheal disease, with an award...
The University of Massachusetts Medical School was awarded a $749,992 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to study the role of SCARF1 in efferocytosis and the prevention of lupus. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
This federal Project Grant award of $707,438 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research to determine the molecular etiology of and strategies to block pancreatic cancer cachexia. The award was made on July 15, 2024 with a performance period ending on July 14, 2027. The prime awardee is the University of Massachusetts Medical School's Grants and Contracts Administration Division, which will conduct the research at their...
The University of Massachusetts Amherst will receive $570,810 through January 31, 2026 from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on intracellular bacterial delivery of vaccine antigens to establish T-cell antitumor immunity in triple-negative breast cancer. The funding will support the university's applied research efforts to transform health care for service members and the public through innovative...
The University of Massachusetts Amherst was awarded a $557,247 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from February 1, 2023 to January 31, 2026 to develop intracellular bacterial delivery of vaccine antigens to establish T-cell antitumor immunity in triple-negative breast cancer. The Military Medical Research and Development program supports innovative medical research with...
The University of Massachusetts Lowell, through its Office of Research Administration-Lowell, has been awarded a $176,000 Project Grant by the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The grant, effective March 1, 2024 through February 28, 2026, will fund research to transform health care for U.S. military service members and the American public through innovative and impactful biomedical research on topics relevant to military medicine. The...
The University of Massachusetts Medical School was awarded a $753,700 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund the development of base editing for gene therapy of ELANE-mutated severe congenital neutropenia from June 1, 2022 to May 31, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals...
The University of Massachusetts Medical School was awarded a $1,005,000 Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to develop pad inhibitors for the treatment of amyotrophic lateral sclerosis (ALS). The award, which commenced on September 30, 2024, will support research activities through September 29, 2026. The Medical School's Grants and Contracts Administration division, doing business as UMms, will lead the project...